1. Chronic Caffeine Consumption, Alone or Combined with Agomelatine or Quetiapine, Reduces the Maximum EEG Peak, As Linked to Cortical Neurodegeneration, Ovarian Estrogen Receptor Alpha, and Melatonin Receptor 2
    Sherine Abdelmissih et al, 2024, Psychopharmacology CrossRef
  2. Three‐year longitudinal cognitive functioning in patients recently diagnosed with bipolar disorder
    I. J. Torres et al, 2020, Acta Psychiatrica Scandinavica CrossRef
  3. The Influence of Prenatal Exposure to Quetiapine Fumarate on the Development of Dopaminergic Neurons in the Ventral Midbrain of Mouse Embryos
    Walaa F. Alsanie et al, 2022, International Journal of Molecular Sciences CrossRef
  4. Simultaneous quantitation of quetiapine and its active metabolite norquetiapine in rat plasma and brain tissue by high performance liquid chromatography/electrospray ionization tandem mass spectrometry (LC-MS/MS)
    Xiangkun Yang et al, 2015, Journal of Chromatography B CrossRef
  5. Comparative evaluation of intranasally delivered quetiapine loaded mucoadhesive microemulsion and polymeric nanoparticles for brain targeting: pharmacokinetic and gamma scintigraphy studies
    Brijesh Shah et al, 2021, Future Journal of Pharmaceutical Sciences CrossRef
  6. The antipsychotic agent quetiapine is increasingly not used as such: dispensed prescriptions in Norway 2004–2015
    Pål Gjerden et al, 2017, European Journal of Clinical Pharmacology CrossRef
  7. The use of quetiapine in the treatment of major depressive disorder: Evidence from clinical and experimental studies
    Zuleide Maria Ignácio et al, 2018, Neuroscience & Biobehavioral Reviews CrossRef
  8. “Application of Box-Behnken design for optimization and development of quetiapine fumarate loaded chitosan nanoparticles for brain delivery via intranasal route* ”
    Brijesh Shah et al, 2016, International Journal of Biological Macromolecules CrossRef
  9. On the treatment of bipolar affective disorder
    N.N. Petrova, 2022, Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova CrossRef
  10. Mood Stabilizers: Quetiapine
    Amanda Silva de Miranda et al, 2022, NeuroPsychopharmacotherapy CrossRef
  11. Development of thiolated polyethylene glycol-poly (lactic-co-glycolic acid) co-polymeric nanoparticles for intranasal delivery of quetiapine: in vitro–ex vivo characterization
    Dilip Patil et al, 2023, International Journal of Polymeric Materials and Polymeric Biomaterials CrossRef
  12. Second‐generation antipsychotic quetiapine blocks voltage‐dependent potassium channels in coronary arterial smooth muscle cells
    Wenwen Zhuang et al, 2024, Journal of Applied Toxicology CrossRef
  13. Assessment of Neurobehavioral Properties of Hydroalcoholic Extract of Benincasa hispida (Thunb.) Cogn. Fruit Pulp in Mice
    Anshul Shakya et al, 2019, Journal of Biologically Active Products from Nature CrossRef
  14. Acute and chronic treatment with quetiapine induces antidepressant-like behavior and exerts antioxidant effects in the rat brain
    Zuleide M. Ignácio et al, 2017, Metabolic Brain Disease CrossRef
  15. Effects of quetiapine administration on sperm quality and testicular histology
    Busra Korkut Celikates et al, 2022, Drug and Chemical Toxicology CrossRef
  16. Comparative efficacy and safety of 4 atypical antipsychotics augmentation treatment for major depressive disorder in adults: A systematic review and network meta-analysis
    Jia Wang et al, 2023, Medicine CrossRef
  17. The Effect of Neuropsychiatric Drugs on the Oxidation-Reduction Balance in Therapy
    Karina Sommerfeld-Klatta et al, 2024, International Journal of Molecular Sciences CrossRef
  18. Non-invasive intranasal delivery of quetiapine fumarate loaded microemulsion for brain targeting: Formulation, physicochemical and pharmacokinetic consideration
    Brijesh Shah et al, 2016, European Journal of Pharmaceutical Sciences CrossRef
  19. Non-interventional epidemiological program for investigating the real-life practice of using quetiapine (Seroquel®) in patients with schizophrenia and bipolar affective disorder (EPIDEMICUS)
    V. E. Medvedev et al, 2023, Neurology, Neuropsychiatry, Psychosomatics CrossRef
  20. The atypical antipsychotic quetiapine induces hyperlipidemia by activating intestinal PXR signaling
    Zhaojie Meng et al, 2019, JCI Insight CrossRef
  21. Mood Stabilizers: Quetiapine
    Amanda Silva de Miranda et al, 2020, NeuroPsychopharmacotherapy CrossRef
  22. The preclinical discovery and development of quetiapine for the treatment of mania and depression
    Aline Silva de Miranda et al, 2017, Expert Opinion on Drug Discovery CrossRef
  23. Quetiapine Dose Adjustments in Pregnant and Postpartum Women With Bipolar Disorder
    Emily A. Pinheiro et al, 2018, Journal of Clinical Psychopharmacology CrossRef
  24. Quetiapine-Related Deaths: In Search of a Surrogate Endpoint
    Ivan Šoša, 2024, Toxics CrossRef